Table 4.
Mortality in the COVID group, univariate analysis
| Survivors (n = 41) | Non-survivors (n = 9) | p | |
|---|---|---|---|
| Clinical data | |||
| Age (years) | 60.1 ± 2.3 | 78.9 ± 5.1 | 0.002 |
| Height (cm) | 174 ± 2 | 169 ± 6 | 0.18 |
| Weight (kg) | 88.1 ± 3.5 | 77.3 ± 7.8 | 0.20 |
| BMI (kg/m2) | 28.9 ± 1.0 | 27.3 ± 2.2 | 0.49 |
| Sex ratio (M/F) | 29/12 | 7/2 | 0.73 |
| Hypertension (%) | 42 | 89 | 0.01 |
| Diabetes (%) | 20 | 33 | 0.42 |
| Smoker (%) | 0.76 | ||
| Never | 89 | 79 | |
| Former | 11 | 19 | |
| Current | - | 2 | |
| COPD (%) | 7 | 44 | 0.003 |
| Renal failure (%) | 14 | 56 | 0.006 |
| Cancer (%) | 11 | 13 | 0.82 |
| CT scan findings | |||
| Thymus CT scan core 0 (%) | 24 | 78 | 0.009 |
| Lung CT scan score | 3 [2–4] | 4 [2–5] | 0.38 |
| Data at admission | |||
| PaO2/FIO2 | 290 ± 31 | 264 ± 51 | 0.65 |
| Haemoglobin (g/L) | 12.0 ± 0.3 | 10.6 ± 0.7 | 0.06 |
| Leukocytes (× 109/L) | 7.6 ± 0.6 | 7.9 ± 1.3 | 0.79 |
| Lymphocytes (× 109/L) | 1.3 ± 0.2 | 0.4 ± 0.4 | 0.05 |
| Lymphocytes (%) | 18 ± 2 | 8 ± 3 | 0.009 |
| Monocytes (× 109/L) | 0.63 ± 0.05 | 0.49 ± 0.11 | 0.27 |
| Monocytes (%) | 11 ± 1 | 7 ± 3 | 0.37 |
| Fibrinogen (g/L)* | 6.34 ± 0.4 | 7.10 ± 1.0 | 0.46 |
| D-dimer (ng/mL)* | 4579 ± 1158 | 4510 ± 2577 | 0.48 |
| CRP (mg/L) | 111 ± 15 | 206 ± 32 | 0.01 |
BMI, body mass index; COPD chronic obstructive pulmonary disease; CRP, C-reactive protein. *34 missing values. Due to multiple comparisons, significance was reached when p < 0.003